Medconmirakoo

About MedConMiraKoo MedConMiraKoo helps emerging and specialty biopharma companies prepare for successful EU launches by bridging medical science, evidence, and access. Based in Switzerland with a physical presence also in the Nordics (Finland), we support early market entry through hands-on medical affairs expertise — from stakeholder engagement and advisory board setup to local evidence generation and HTA alignment. Focus areas: • Rare and neuromuscular diseases • Gene and advanced therapies • Real-world evidence and registry strategy • Medical launch readiness (Nordics & EU) How we work: Independent, project-based collaboration (B2B) for companies not yet ready to build full local teams. We connect scientific data to healthcare practice, enabling faster and better-informed EU market access. Keywords: medical affairs, EU launch readiness, rare disease, market access, evidence generation, HTA, Nordic biotech.